Company Announces Appointment of Dr. Mark Wagner to Board of Directors
ANAHEIM, Calif., Oct. 09, 2018 (GLOBE NEWSWIRE) — GreenGro Technologies, Inc. (OTC: GRNH), a world-class provider of eco-friendly green technologies, today announced the launch of its newly formed CBD Subsidiary, EMS Meds, Inc., which will focus on the research and development of a full line of premium CBD products that will be distributed directly to doctors’ offices, medical facilities and specialty retailers.
Today’s announcement is a result of the GreenGro’s formation of EMS Meds, Inc. (www.educationalmarijuanasciences.com), to develop new and innovative medicines and treatments that are derived from CBD, the non-psychoactive component in cannabis that is known for its health and wellness benefits. As part of the strategic alliance, Dr. Mark Wagner, Founder and CEO of EMS Meds, Inc. has been appointed to the Board of Directors of GreenGro Technologies.
EMS Meds will serve as the GreenGro’s clinical arm dedicated to the production of CBD-based medicines and treatments. GreenGro noted that its targeted distribution network, which should be covered by most insurance carriers, will make its CBD products available to a large number of patients who until today could not afford CBD-derived medications
“The CBD market is growing everyday as more and more consumers are learning how powerful CBD can be as an all-natural alternative to opioids, and can be a natural remedy for such ailments as asthma, insomnia, anxiety, depression, arthritis, among others,” said James Haas, Chairman and CEO of GreenGro Technologies, Inc. “Our entry into this significant market was a natural next step for our company as we strive to add new revenue streams to our business model and focus on enhancing shareholder value,” concluded Mr. Haas.
Company Adds CBD Pioneer to Board of Directors
As part of the Company’s strategic alliance with EMS Meds, Inc., its Founder and CEO, Dr. Mark Wagner, has been added to the Company’s Board of Directors. Dr. Wagner currently also serves as the Director of OC Comprehensive Care in Santa Ana. He graduated Phi Beta Kappa from the University of California, Irvine with degrees in Biology and Chemistry prior to attending UCLA School of Medicine. After completing an Emergency Medicine Residency at Harbor UCLA, he practiced Emergency Medicine for 30 years throughout Los Angeles and Orange County. Dr. Wagner is an advocate for the indigent and underinsured and served as an independent appeals and grievance consultant for a major health insurance plan in the past. At OC Comprehensive Care, Dr. Wagner and his associates specialize in treating patients who are very commonly ignored by their primary providers due to chronic pain, anxiety, depression, mood disorders, ADD/ADHD, PTSD, or other poorly understood conditions. Dr. Wagner has researched the benefits of medicinal hemp and cannabis and consults patients on individualizing their treatment plan utilizing hemp and cannabis to reduce the burden of controlled substances and psychotropic pharmaceuticals that have recognized and sometimes dangerous and lethal consequences. By joining GreenGro Technologies, Dr. Wagner will have the ability to research, develop, and market quality branded medicinal hemp and cannabis products.
The Multi-Billion Dollar and Growing Cannabidiol (CBD) Market
CBD is a non-psychoactive cannabinoid proving to be useful as an anti-inflammatory, antioxidant and neuroprotectant. As such, CBD is being used in the treatment of a number of conditions including cancer, pain and inflammation and GI tract issues, among others. As researchers and institutions have developed a better understanding of its positive impacts, there have been regulatory changes aimed at breaking down the entry barriers into the CBD market. One notable instance of this is the recent announcement from the World Anti-Doping Agency (WADA) in which the organization removed CBD from its prohibited substances list. Its reasoning is that CBD does not mimic the effects of tetrahydrocannabinol (THC)—the psychoactive component of cannabis.
Or like our Facebook page @
About GreenGro Technologies
GreenGro Technologies (GRNH) is a world class provider of eco-friendly green technologies with specific domain expertise in indoor and outdoor agricultural science systems serving both the consumer and commercial farming markets. It brings together community and commerce through the growth and distribution of healthy, nutritious foods and vital medicines backed by science and technology. Customers include restaurants, community gardens, small- and large-scale commercial clients. GreenGro Technologies also provides design, construction and maintenance services to large grow and cultivation operations and collectives in the medical and recreational marijuana sectors. The Company’s website at www.greengrotech.com offers regular updates including educational videos, projects updates, recipes and nutritional information, and where to find the Company’s products.
Disclaimer: The Company relies upon the Safe Harbor Laws of 1933, 1934 and 1995 for all public news releases. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are necessarily estimates reflecting the company’s best judgment based upon current information and involve several risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors. Factors which could cause actual results to differ materially from those estimated by the company include, but are not limited to, government regulation; managing and maintaining growth; the effect of adverse publicity; litigation; competition; and other factors which may be identified from time to time in the company’s public announcements.
The post GreenGro Technologies Announces Launch of CBD Division appeared first on Canna Equities.